Light Mode
$81.12 ↑ +0.00 (+0.00%) Trading Up from the previous close of $81.12, $4.19 below the day’s high of $85.31
+34.60 (+74.38%) / 6M
Momentum, market sentiment, and recent alerts
CORT reads not so good: price sits above one of the two key moving averages, the 12-month move is +12.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.